Price Alert

Bright Minds Biosciences ... (DRUG)

NASDAQ: DRUG · Real-Time Price · USD

66.40

-1.64 (-2.41%)

At close: Oct 16, 2025, 3:59 PM

66.40

0.00%

After-hours: Oct 16, 2025, 07:16 PM EDT

-2.41% (1D)

Bid	66.4
Market Cap	470.44M
Revenue (ttm)	n/a
Net Income (ttm)	-8.89M
EPS (ttm)	-0.98
PE Ratio (ttm)	-67.76
Forward PE	-13.49
Analyst	Buy
Dividends	n/a

Ask	70.5
Volume	108,126
Avg. Volume (20D)	78,203
Open	67.01
Previous Close	68.04
Day's Range	63.70 - 70.19
52-Week Range	21.10 - 79.02
Beta	-0.35
Ex-Dividend Date	n/a

About DRUG

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol DRUG

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for DRUG stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

3 months ago

+3.36%

Shares of psychedelic companies are trading higher... Unlock content with Pro Subscription

10 months ago

-1.24%

Bright Minds Biosciences shares are trading higher after Baird initiated coverage on the stock with an Outperform rating and announced a price target of $75.

News

1 day ago · zacks.com

Bright Minds Biosciences Inc. (DRUG) is on the Move, Here's Why the Trend Could be Sustainable

Bright Minds Biosciences Inc. (DRUG) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks tha...

4 weeks ago · zacks.com

Wall Street Analysts Believe Bright Minds Biosciences Inc. (DRUG) Could Rally 81.29%: Here's is How to Trade

The consensus price target hints at an 81.3% upside potential for Bright Minds Biosciences Inc. (DRUG). While empirical research shows that this sought-after metric is hardly effective, an upward tren...

1 month ago · zacks.com

Does Bright Minds Biosciences Inc. (DRUG) Have the Potential to Rally 114.07% as Wall Street Analysts Expect?

The consensus price target hints at an 114.1% upside potential for Bright Minds Biosciences Inc. (DRUG). While empirical research shows that this sought-after metric is hardly effective, an upward tre...